SCHEMBL29703239

SCHEMBL29703239

O=c1c2ccccc2cnn1Cc1ccc(F)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.69
RXFP1 Q9HBX9 3/20 0.59
LMNA P02545 1/20 0.59
PKM P14618 4/20 0.58
MITF O75030 2/20 0.58
RAB9A P51151 2/20 0.58
HTT P42858 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
POLB P06746 1/20 0.56
CASP3 P42574 1/20 0.50
NPC1 O15118 1/20 0.50
KDM4E B2RXH2 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ALDH1A1 P00352 2/20 0.47
APOBEC3G Q9HC16 1/20 0.47
HPGD P15428 1/20 0.47
MAPT P10636 1/20 0.47
PKLR P30613 1/20 0.47
AURKA O14965 1/20 0.46
AURKB Q96GD4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7894526 1.00 TDP1 (0.69) TDP1RXFP1LMNAPKMMITF
SCHEMBL29703247 0.88 TDP1 (0.72) TDP1RXFP1LMNAPKMMITF
SCHEMBL9027681 0.88 TDP1 (0.72) TDP1RXFP1LMNAPKMMITF
Hydrochloric Acid SCHEMBL30088832 0.86 TDP1 (0.70) TDP1RXFP1LMNAPKMMITF
SCHEMBL30579886 0.82 TDP1 (0.64) TDP1PKMMITFRAB9AHTT
SCHEMBL24754238 0.78 TDP1 (0.59) TDP1LMNAPKMMITFRAB9A
SCHEMBL6216387 0.76 NPC1 (0.64) TDP1RXFP1LMNAPKMMITF
SCHEMBL30376204 0.76 TDP1 (0.57) TDP1PKMMITFRAB9AHTT
SCHEMBL25468396 0.76 TDP1 (0.57) TDP1PKMMITFRAB9AHTT
SCHEMBL24169032 0.75 HDAC6 (0.59) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220235011-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF ST PHARM CO., LTD. (KR) 2022-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220235011-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF SIRT6, SIRT1, SIRT2 TDP1 4688/4885RXFP1 1244/4885LMNA 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.